Augustinus Foundation

The Augustinus Foundation (Augustinus Fonden) is a prominent Danish commercial foundation and a key institutional investor in the global life sciences sector. Through its investment subsidiary, Augustinus Industri A/S, the foundation maintains significant long-term ownership in Novonesis, the global bioscience leader formed by the merger of Chr. Hansen and Novozymes. The foundation acts as a stable anchor shareholder, supporting companies focused on enzyme technology, microbial solutions, and sustainable ingredients. In addition to its commercial holdings, the foundation is a major philanthropic force in Denmark, providing extensive funding for medical research, cultural preservation, and social initiatives. Its dual role as an industrial owner and a charitable grantor makes it a central pillar of the Danish scientific and economic landscape.